Minerva Surgical, Inc.
- Sector: Healthcare
- Industry: Medical Devices
- Website: https://minervasurgical.com
- Address: 4255 Burton Drive, Santa Clara, CA, 95054, United States
- Phone: 855 646 7874
Minerva Surgical, Inc. is a medical technology company that specializes in developing and commercializing minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers a range of products, including endometrial ablation devices, a tissue removal system, and a tissue resection device. These devices are utilized by obstetrician-gynecologists in various medical treatment settings.
The company is headquartered in Santa Clara, California and has a team of 174 full-time employees. The executive team is led by Mr. Todd Usen, who serves as the President, CEO, and Director of the company.
Financial Overview
- Market Cap: $4,084,146
- Enterprise Value: $36,954,076
- Previous Close: $0.51
- Open: $0.51
- Day Range: $0.45 – $0.55
- 52-Week Range: $0.30 – $14.00
- Volume: 7,330
- Average Volume: 2,435
- P/E Ratio (TTM): -0.1592
- EPS (TTM): -$7.61
- Forward P/E: -0.1592
- Dividend Yield: N/A
- Beta: 0.682
Financial Analysis
Minerva Surgical, Inc. is currently facing challenges in terms of its financial performance. The company reported a negative profit margin of -64.71% and a negative return on assets and equity, indicating poor financial health.
The company's revenue has been declining, with a revenue growth rate of -4.9% in the last fiscal year. Additionally, the company's earnings per share (EPS) is negative, indicating a loss-making situation. The company's high debt-to-equity ratio of 215.014 further raises concerns about its financial stability.
Despite the negative financial indicators, the company has a recommendation key of "buy" from analysts, suggesting potential future growth. However, it is important to note that there is only one analyst opinion available.
Stock Price Prediction
Based on historical data, the stock price of Minerva Surgical, Inc. has been highly volatile, with a 52-week range of $0.30 to $14.00. The stock is currently trading at $0.46, which is significantly lower than its 52-week high.
Given the company's negative financial indicators and declining revenue, it is difficult to predict the future stock price with certainty. However, it is likely that the stock price will remain volatile in the short term, as investor sentiment and market conditions continue to impact the performance of the company.
Conclusion
Minerva Surgical, Inc. is a medical technology company that is facing financial challenges, with negative profit margins and declining revenue. While the stock price has been highly volatile, the company has received a "buy" recommendation from analysts, indicating potential future growth. However, investors should exercise caution and closely monitor the company's financial performance before making any investment decisions.
